• 04.01.13

    Firm Founder Jerry W. Blackwell to Present at DRI Product Liability Conference

    Firm founder and chairman Jerry W. Blackwell will participate in two sessions at the 2013 DRI Product Liability Conference: Make Your Products Practice Bloom.  The DRI conference is being held April 3-5 near Washington, D.C.  Leading regulators, manufacturers, and attorneys will present on minimizing liability before and during product liability litigation. Top national attorneys, including Mr. Blackwell, will demonstrate voir dire, case theme development, and closing arguments. On Wednesday, April 3, 2013, Mr. Blackwell will participate in a panel entitled, “Reap What You Sow: Using Technology to Pick the Right Jurors.”  He and his co-panelists will discuss how to analyze…
  • 02.19.13

    Firm Founder Jerry W. Blackwell Named a BTI Client Service All-Star for Providing the “Absolute Best” in Client Service

    Firm founder and chairman Jerry W. Blackwell has been named a 2013 BTI Client Service All-Star.  The honor recognizes those who provide the "absolute best" in client service among attorneys representing Fortune 1000 companies. The BTI Client Service All-Stars list annually recognizes attorneys who, according to Fortune 1000 companies, drive superior client service. Only approximately 300 attorneys receive this recognition nationwide each year.  This is the second time that Mr. Blackwell has received the honor.  For more details about the 2013 BTI Client Service All-Stars, please visit BTI Consulting Group’s website. The BTI Consulting Group is a market leader in research…
  • 02.14.13

    Blackwell Burke P.A. Named a “2013 Go-To Law Firm” at the Top 500 Companies by Corporate Counsel Magazine

    Blackwell Burke P.A. was named a “2013 Go-To Law Firm” at the Top 500 Companies by Corporate Counsel.  This award recognizes law firms who complete exceptional legal work for Fortune 500 companies as identified by in-house counsel.  We thank our colleagues and friends at General Mills, Inc. and ConAgra Foods, Inc. for this honor. Blackwell Burke P.A., a litigation and trial boutique, serves as national trial and litigation counsel for numerous Fortune 500 companies. We are a minority-owned Minneapolis-based law firm with a national practice and winning record.  Our litigators and trial lawyers are committed to the relentless pursuit of excellence…
  • 01.30.13

    Blackwell Burke P.A. Partner Corey L. Gordon to Speak on Diacetyl at Grocery Manufacturers Association Conference

    Blackwell Burke P.A. partner Corey L. Gordon will present at the Grocery Manufacturers Association (GMA) 2013 Litigation Conference. The GMA Conference is being held February 19-21, 2013 in Miami, Florida. Mr. Gordon’s presentation will take place on Wednesday, February 20. The GMA is the main trade group of the food industry. Its members include the makers of food, beverages, and other consumer products. Mr. Gordon’s presentation is entitled, “Is Diacetyl the New Asbestos? Flavoring Litigation in the Post-Watson World.”  He will discuss Diacetyl, an additive used in many food products to give it a buttery flavor.  Diacetyl has been a…
  • 01.30.13

    Peter J. Goss Discusses How Bankruptcy May Affect Consolidation of Meningitis Claims in Law 360

    Law360 interviewed Blackwell Burke P.A. partner Peter J. Goss for an article about the U.S. Judicial Panel on Multidistrict Litigation’s (JDML) upcoming hearing on whether to centralize over 100 cases filed against the New England Compounding Center (NECC). These lawsuits arise from the NECC’s distribution of allegedly tainted steroids that resulted in meningitis. The decision whether and where to centralize the steroid injury cases is complicated by the NECC’s Chapter 11 bankruptcy filing in Massachusetts at the end of 2012.  Both Massachusetts (where NECC is located) and Minnesota (where the first cases were filed) have been proposed as consolidation venues. Mr.…
  • 01.15.13

    Law 360 Quotes Blackwell Burke P.A. Partner Peter J. Goss on Innovator Liability for Generic Drug Injuries

    Law360 interviewed Blackwell Burke P.A. partner Peter J. Goss for an article about a recent Alabama Supreme Court ruling that branded pharmaceutical manufacturers could be liable for failure to warn in cases where the patient only took a generic version of the drug.  This is the first decision to address the issue of “innovator liability” for generic drug injuries since the U.S. Supreme Court’s decision in PLIVA, Inc. v. Mensing (2011), which held that failure-to-warn claims against generic drug manufacturers are preempted by the Hatch-Waxman Act. Mr. Goss explained that courts are struggling with the real-world consequences of Mensing, which effectively absolved generic…

Interested in learning more?

Email Disclaimer Close

Sending us an email will not make you a client of our firm. Until we have agreed to represent you, nothing you send us will be confidential or privileged.

If your email is related to representation, the best way for you to inquire about a possible representation is to call a Blackwell Burke P.A. attorney at one of the telephone numbers listed on our Attorney's page. An attorney will first take you through our conflict of interest procedure and see that you are put in touch with the lawyer best suited to handle your matter.

If you proceed with an email, you confirm that you have read and understand this notice. To proceed, click I Agree.